Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV.
Kennedy AJ, McGinnis KA, Merlin JS, Edelman EJ, Gordon AJ, Korthuis PT, Skanderson M, Williams EC, Wyse J, Oldfield B, Bryant K, Justice A, Fiellin DA, Kraemer KL. Kennedy AJ, et al. Among authors: korthuis pt. J Subst Abuse Treat. 2022 Jan;132:108509. doi: 10.1016/j.jsat.2021.108509. Epub 2021 May 29. J Subst Abuse Treat. 2022. PMID: 34130128 Free PMC article.
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.
Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, Cunningham CO, Sullivan LE, Vergara-Rodriguez P, Fiellin DA, Cajina A, Botsko M, Nandi V, Gourevitch MN, Finkelstein R; BHIVES Collaborative. Altice FL, et al. Among authors: korthuis pt. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(Suppl 1):S22-32. doi: 10.1097/QAI.0b013e318209751e. J Acquir Immune Defic Syndr. 2011. PMID: 21317590 Free PMC article. Clinical Trial.
The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation.
Schackman BR, Leff JA, Botsko M, Fiellin DA, Altice FL, Korthuis PT, Sohler N, Weiss L, Egan JE, Netherland J, Gass J, Finkelstein R; BHIVES Collaborative. Schackman BR, et al. Among authors: korthuis pt. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(Suppl 1):S76-82. doi: 10.1097/QAI.0b013e31820a9a66. J Acquir Immune Defic Syndr. 2011. PMID: 21317599 Free PMC article.
Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine.
Korthuis PT, Fiellin DA, Fu R, Lum PJ, Altice FL, Sohler N, Tozzi MJ, Asch SM, Botsko M, Fishl M, Flanigan TP, Boverman J, McCarty D; BHIVES Collaborative. Korthuis PT, et al. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(Suppl 1):S83-90. doi: 10.1097/QAI.0b013e31820bc9a5. J Acquir Immune Defic Syndr. 2011. PMID: 21317600 Free PMC article.
Unhealthy alcohol and illicit drug use are associated with decreased quality of HIV care.
Korthuis PT, Fiellin DA, McGinnis KA, Skanderson M, Justice AC, Gordon AJ, Doebler DA, Asch SM, Fiellin LE, Bryant K, Gibert CL, Crystal S, Goetz MB, Rimland D, Rodriguez-Barradas MC, Kraemer KL. Korthuis PT, et al. J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):171-8. doi: 10.1097/QAI.0b013e31826741aa. J Acquir Immune Defic Syndr. 2012. PMID: 22820808 Free PMC article.
HIV rapid testing in drug treatment: comparison across treatment modalities.
Schwartz RP, Stitzer ML, Feaster DJ, Korthuis PT, Alvanzo AA, Winhusen TM, Donnard L, Snead N, Metsch LR. Schwartz RP, et al. Among authors: korthuis pt. J Subst Abuse Treat. 2013 Apr;44(4):369-74. doi: 10.1016/j.jsat.2012.08.219. Epub 2012 Sep 27. J Subst Abuse Treat. 2013. PMID: 23021496 Free PMC article. Clinical Trial.
Patient activation and improved outcomes in HIV-infected patients.
Marshall R, Beach MC, Saha S, Mori T, Loveless MO, Hibbard JH, Cohn JA, Sharp VL, Korthuis PT. Marshall R, et al. Among authors: korthuis pt. J Gen Intern Med. 2013 May;28(5):668-74. doi: 10.1007/s11606-012-2307-y. J Gen Intern Med. 2013. PMID: 23288378 Free PMC article.
Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.
Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Lau B, Althoff KN, Crane HM, Collier AC, Samji H, Thorne JE, Gill MJ, Klein MB, Martin JN, Rodriguez B, Rourke SB, Gange SJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS. Hanna DB, et al. Among authors: korthuis pt. Clin Infect Dis. 2013 Apr;56(8):1174-82. doi: 10.1093/cid/cit003. Epub 2013 Jan 11. Clin Infect Dis. 2013. PMID: 23315317 Free PMC article.
234 results